Skip to main content
. 2012 May 9;4(1):77–83. doi: 10.1159/000338759

Table 1.

Changes in the antiparkinsonian medication and the behavior of the patient

Time after diagnosis years Medication, daily dose Non-motor behavioral changes
0 Diagnosis of Parkinson's disease, selegiline 5 mg
1 Selegiline 5 mg, cabergoline 1 mg
2 Selegiline 5 mg, cabergoline 2 mg
3 Selegiline 5 mg, cabergoline 2 mg, levodopa/carbidopa 100/25 mg
5 Selegiline 10 mg, cabergoline 2 mg, levodopa/carbidopa 200/50 mg Pathological gambling, punding
7 Selegiline 10 mg, cabergoline 2 mg, levodopa/carbidopa 200/50 mg Creativity, pathological gambling, punding
9 PET imaging, selegiline 10 mg, cabergoline 2 mg, levodopa/carbidopa 300/75 mg Creativity, pathological gambling, punding
10 Selegiline 10 mg, pramipexole 0.18 mg, levodopa/carbidopa/entacapone 750/187.5/1,000 mg under consideration for deep brain stimulation Creativity, punding